Breast cancer is a heterogeneous disease with numerous subtypes at the molecular level, including triple-negative breast cancer (TNBC), hormone receptor-positive (HR+) breast cancer, and human epidermal growth factor receptor 2-positive (HER2+) breast cancer, each with its own implications for treatment. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.